Want to join the conversation?
Biotech company $SPPI said it has reached an agreement with the US FDA on the Special Protocol Assessment (SPA) for the Registrational Trial of SPI-2012 (eflapegrastim), a novel, long acting G-CSF in patients with breast cancer. $SPPI expects to start the pivotal trial shortly and plans to complete enrollment in 2017.
$GOOG’s Waymo accuses Uber of stealing its intellectual property. Startup Otto, which was recently acquired by Uber, also named in the lawsuit. Stage set for another dramatic legal battle!
We all knew $VALE CEO Murilo Ferreira was going out soon, but now I hear he has no idea who will succeed him!
$JCP, another traditional retailer that just shocked us with its biggest number of store closures.